India Launches First Cancer Multi-Omics Data Portal to Enhance Research and Treatment Protocols

An innovative cancer data portal has been introduced by the Indian Cancer Genome Atlas (ICGA), offering open access to vital information from Indian cancer patients. This resource aims to assist researchers and clinicians in crafting personalised treatment strategies. Currently, the platform includes data from 50 breast cancer patients, with plans to expand to over 500 patients within a year.

The ICGA Foundation, a Section 8 not-for-profit organisation, operates through a public-private-philanthropic partnership. It receives support from more than 50 clinicians, researchers, and data analysts. The initiative aligns with India's PRIDE guidelines, promoting ethical sharing and collaboration in cancer research.

Open Access to Cancer Data

The ICGA claims this is India's first platform providing open access to data from Indian cancer patients. This initiative aims to revolutionise cancer research and treatment for Indian populations. Historically, treatments in India have relied on Western data sets, which may not accurately reflect the molecular differences in Indian patients.

The ICGA's mission is to create datasets specific to India. This will aid researchers and clinicians in developing personalised treatment protocols. The multi-omics portal is the first in India to offer comprehensive data, including DNA, RNA, and protein profiles of breast cancer patients, integrated with clinical outcomes.

Collaborative Efforts and Global Impact

Professor Shekhar C Mande, a Senior Professor at Savitribai Phule Pune University, emphasised the significance of making this invaluable cancer data publicly accessible. "Making this invaluable cancer data publicly accessible marks a pivotal step in accelerating scientific discoveries and enhancing patient outcomes," he stated.

In a joint statement, Dr JC Zenklusen of The Cancer Genome Atlas (TCGA) at the NCI, USA, and Professor Sunil Badve of University School of Medicine, Georgia, USA, encouraged others with similar data to contribute actively to ICGA. They noted that understanding the genome of cancer patients will improve treatment for Indians globally.

Encouraging Contributions

Dr Anand Deshpande, Chairman and Managing Director at Persistent and Non-Executive Director at ICGA, praised the launch of this multi-omics cancer portal. He highlighted the urgent need for effective treatments tailored to India's unique genetic and environmental factors.

"Cancer touches all of us," Deshpande remarked. "This portal will empower researchers with crucial data to advance customized cancer research for better treatment outcomes." He urged everyone to contribute and support this vital cause to accelerate progress in combating cancer.

The Indian Cancer Genome Atlas (ICGA) is a national initiative focused on mapping the genomic, transcriptomic, and proteomic landscapes of cancers across India. This effort aims to provide comprehensive insights into the unique characteristics of cancers affecting Indian populations.